CARGO Therapeutics (CRGX) to Discontinue FIRCE-1 Phase 2 Study of Firi-cel Jan 29, 2025 04:08PM
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options Jan 29, 2025 04:05PM
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025 Jan 10, 2025 08:00AM
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference Dec 17, 2024 08:00AM
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Nov 12, 2024 04:05PM


Nov 5, 2024 04:05PM CARGO Therapeutics to Participate in Upcoming Investor Conferences
Nov 5, 2024 09:23AM CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
Aug 12, 2024 04:05PM CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Jul 10, 2024 08:02AM CARGO Therapeutics (CRGX) Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Jul 10, 2024 08:00AM CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
Jun 4, 2024 04:05PM CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
May 28, 2024 08:05AM CARGO Therapeutics to Participate in Upcoming Investor Conferences
May 14, 2024 04:05PM CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Apr 15, 2024 04:06PM CARGO Therapeutics (CRGX) Appoints Kapil Dhingra to its Board
Apr 15, 2024 04:05PM CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Mar 21, 2024 04:05PM CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Jan 3, 2024 08:05AM CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Dec 13, 2023 04:05PM CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results